Experimental study demonstrates fraxin improves antioxidant parameters in mesenteric ischemia, suggesting therapeutic potential.
Fraxin administration preserved tissues and improved antioxidant parameters by reducing oxidative stress and inflammation in the acute mesenteric artery ischemia-reperfusion injury (AMAIRI) model. Based on these findings, fraxin may be considered a potential therapeutic option for mesenteric ischemia-reperfusion-related injuries.
No takes yet. Share an insight, caveat, or question.
Aydin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: